Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
ACS Chemical Biology|November 3, 2021
Identification of Dihydroorotate Dehydrogenase Inhibitors─Indoluidins─That Inhibit Cancer Cell GrowthMakoto Kawatani, Harumi Aono, Takeshi Shimizu, et al.
ACS Chemical Biology|July 23, 2021
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell GrowthMakoto Kawatani, Harumi Aono, Sayoko Hiranuma, et al.
Oncology Research|September 25, 2023
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profilingMakoto Kawatani, Harumi Aono, Sayoko Hiranuma, et al.
Oncotarget|June 2, 2018
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinomaShunsuke Itai, Tomokazu Ohishi, Mika K Kaneko, et al.
The Journal of Antibiotics|May 2, 2013
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2Manabu Kawada, Hiroyuki Inoue, Shun-Ichi Ohba, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|August 23, 2021
Defucosylated Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 134-mG2a-f Exerts Antitumor Activities in Mouse Xenograft Models of Dog Epidermal Growth Factor Receptor-Overexpressed CellsNami Tateyama, Ren Nanamiya, Tomokazu Ohishi, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|March 18, 2020
Antibody-Drug Conjugates Using Mouse-Canine Chimeric Anti-Dog Podoplanin Antibody Exerts Antitumor Activity in a Mouse Xenograft ModelYukinari Kato, Yuji Ito, Tomokazu Ohishi, et al.
Biochemistry and Biophysics Reports|August 15, 2018
Podocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2Shunsuke Itai, Shinji Yamada, Mika K Kaneko, et al.
The Journal of Biological Chemistry|August 29, 2025
Loss of Angulin-1/LSR promotes vasculogenic mimicry and epithelial-mesenchymal transition in breast cancerYuma Yoshioka, Chisato Nosaka, Tomokazu Ohishi, et al.
Helicobacter|March 1, 2018
Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infectionTomokazu Ohishi, Tohru Masuda, Hikaru Abe, et al.
Pageof 14